X0206 3 2021-12-23 0 0001822711 PARDES BIOSCIENCES, INC. PRDS 0001797160 Tinmouth Brian Philippe C/O PARDES BIOSCIENCES, INC. 2173 SALK AVE., SUITE 250, PMB #052 CARLSBAD CA 92008 0 1 0 0 Chief Business & Strategy Ofcr Stock Option (Right to Buy) 4.94 2031-07-26 Common Stock 28156 D Stock Option (Right to Buy) 8.19 2031-11-22 Common Stock 422340 D 50% of the shares subject to such option vest and become exercisable on June 23, 2022, and 1/24th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on the 23rd day of each month thereafter, subject to a continued service relationship. 1/4th of the shares subject to such option vest and become exercisable on November 22, 2022, and 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on the 22nd day of each month thereafter, subject to a continued service relationship. Exhibit 24 - Power of Attorney Effective immediately following the effective time of the merger pursuant to that certain Agreement and Plan of Merger dated as of June 29, 2021, as amended, by and among Pardes Biosciences Sub, Inc. (f/k/a Pardes Biosciences, Inc.), Issuer (f/k/a FS Development Corp. II), and certain other parties thereto, the reporting person became an officer of the Issuer. /s/ Elizabeth Lacy, attorney-in-fact 2021-12-27